(Q28195764)

English

Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk

scientific article (publication date: 2006)

In more languages

edit

Statements

0 references

3 references

Europe PubMed Central

28 October 2020

19 July 2021

Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk (English)

0 references

main subject

non-steroidal anti-inflammatory drug

1 reference

stated in

PubMed

retrieved

28 October 2020

anti-inflammatory agent

1 reference

19 July 2021

Lawrence Goldkind

1

0 references

Lee S Simon

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2006

0 references

2 March 2006

2 references

28 October 2020

19 July 2021

Arthritis Research and Therapy

2 references

28 October 2020

19 July 2021

8

0 references

issue

2

0 references

page(s)

105

0 references

cites work

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

20 March 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

2 references

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

20 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

6 April 2017

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

7 April 2017

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

29 September 2017

Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

27 November 2018

When is a medical product too risky? An interview with FDA's top drug official. Interview by Tamar Nordenberg.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526603

retrieved

27 November 2018

Identifiers

DOI

10.1186/AR1924

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

7237199

0 references

Springer Nature article ID

10.1186/ar1924

0 references

(Q28195764)

Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)